OxyContin billionaire is now trying to get you off OxyContin
The man who made billions by selling the highly addictive drug OxyContin has received a patent to sell an opioid treatment.
Richard Sackler, the former chairman and president of the OxyContin maker Purdue Pharma, is one of six inventors listed on a patent "for a new formulation of buprenorphine," Axios reported Friday. The invention is a variation of buprenorphine, a mild opiate that is often used as an OxyContin substitute and a common treatment for opioid addiction, the Financial Times reports. The patent was granted earlier this year.
The inventors could stand to make a lucrative profit from the drug due to the increased need for milder opioid alternatives as the country grapples with a devastating and deadly opioid epidemic. In 2017, British pharmaceuticals group Indivior earned more than $800 million from U.S. sales of buprenorphine, per FT.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Purdue Pharma, owned by Sackler's family, is currently being sued by more than 1,000 jurisdictions for its involvement in the opioid crisis, Stat reports. The family has denied responsibility.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Marianne is The Week’s Social Media Editor. She is a native Tennessean and recent graduate of Ohio University, where she studied journalism and political science. Marianne has previously written for The Daily Beast, The Crime Report, and The Moroccan Times.
-
The African asylum seekers fighting for Israel in Gaza
Under the Radar 'Quid pro quo' recruitment offer condemned as unethical as Israel seeks to address shortage of soldiers
By The Week Staff Published
-
Instagram rolls out teen accounts with new limits
Speed Read After facing pushback over child safety, Meta announced that all users under 18 will have their Instagram accounts modified
By Peter Weber, The Week US Published
-
Arizona official sues to bar 100K from local voting
Speed Read A large number of residents who have not submitted citizenship documents might be prevented from voting in the battleground state's elections
By Rafi Schwartz, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published